Cynosure Inc. (CYNO) CFO Timothy W Baker buys 2,500 Shares

Author's Avatar
Feb 28, 2009
Executive VP, CFO, Treasurer of Cynosure Inc. (CYNO, Financial) Timothy W Baker buys 2,500 shares of CYNO on 02/25/2009 at an average price of $5.9 a share.

Cynosure Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive procedures to remove hair treat vascular lesions rejuvenate skin through the treatment of shallow vascular and pigmented lesions and temporarily reduce the appearance of cellulite. Cynosure's products incorporate a broad range of laser and other light-based energy sources including Alexandrite pulse dye Nd:Yag and diode lasers as well as intense pulsed light. Cynosure Inc. has a market cap of $79.73 million; its shares were traded at around $5.48 with a P/E ratio of 7.1 and P/S ratio of 0.57.

CYNO is in the portfolios of Charles Brandes of Brandes Investment.

Recent Trades of Cynosure Inc. by CEO:
  • Buy: President, CEO & Chairman Michael R Davin bought 2,500 shares of CYNO stock on 02/25/2009 at the average price of $5.9; the price of the stock has decreased by 7.12% since.

  • Buy: President, CEO & Chairman, Director Michael R Davin bought 2,500 more shares of CYNO stock on 11/12/2008 at the average price of $8.3; the price of the stock has decreased by 33.98% since.



Recent Trades of Cynosure Inc. by CFO:
  • Buy: Executive VP, CFO, Treasurer Timothy W Baker bought 2,500 shares of CYNO stock on 02/25/2009 at the average price of $5.9; the price of the stock has decreased by 7.12% since.

  • Buy: Executive VP, CFO, Treasurer Timothy W Baker bought 2,500 more shares of CYNO stock on 11/12/2008 at the average price of $8; the price of the stock has decreased by 31.5% since.



Recent Trades of Cynosure Inc. by Directors and Officers:
  • Buy: Director Paul F Kelleher bought 6,000 shares of CYNO stock on 10/30/2008 at the average price of $8.94; the price of the stock has decreased by 38.7% since.